Discover how GLP-1 weight loss medications like Ozempic and Wegovy are linked to reduced risks of dementia heart disease and more—alongside potential side effects to consider ...

New data from Axios credits tough talk by Republicans led to fewer illegal border crossings and fewer arrests of unlawful ...

For all the buzz surrounding weight loss medications like semaglutide and tirzepatide, these drugs aren’t perfect. They come with a risk of side effects like nausea and diarrhea ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as ...

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

US rival Eli Lilly last month forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street estimates, leading the stock to fall 8%. The shares have since recovered. "We see an ...

As many as 17% of men and 34% of women in the United States suffer from sleep apnea, and the numbers are increasing. KYW medical editor Dr. Brian McDonough has more.

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist Wegovy (semaglutide) have shown experimentally what has been ...

The NHS offers the mpox vaccine to those deemed a higher risk of catching the virus, such as men who have sex with other men and have multiple partners. Read more: How is new strain of mpox found in ...